Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

China’s embrace of embryo selection raises thorny questions

A Correction to this article was published on 24 August 2017

This article has been updated

Fertility centres are making a massive push to increase preimplantation genetic diagnosis in a bid to eradicate certain diseases.

Victor Fraile/Corbis/Getty

China’s move to a two-child policy has been a boon for fertility clinics.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 18 August 2017

    The photo originally leading this story depicted infants in a hospital in Hong Kong, which was not relevant to the subject matter. It has therefore been deleted.

Authors

Related links

Related links

Related links in Nature Research

CRISPR fixes disease gene in viable human embryos 2017-Aug-02

Secrets of life in a spoonful of blood 2017-Feb-07

Should you edit your children’s genes? 2016-Feb-23

Reproductive medicine: The power of three 2014-May-21

Making babies: the next 30 years 2008-Jul-16

Related external links

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cyranoski, D. China’s embrace of embryo selection raises thorny questions. Nature 548, 272–274 (2017). https://doi.org/10.1038/548272a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/548272a

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research